Cargando…

Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis

BACKGROUND: Zoledronic acid is a potent inhibitor of osteoclast-mediated bone resorption and has been widely used in bone metastasis malignancies and postmenopausal osteoporosis as a preventive therapy against skeletal-related events. The purpose of this study was to evaluate the clinical outcome of...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Mingfeng, Fan, Weidong, Zhang, Xianquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874690/ https://www.ncbi.nlm.nih.gov/pubmed/24283946 http://dx.doi.org/10.1186/1756-8722-6-80

Ejemplares similares

Zoledronic Acid as an Adjuvant Therapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis
por: Huang, Wei-Wei, et al.
Publicado: (2012)

Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis
por: Zhou, Wen-Bin, et al.
Publicado: (2011)

Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
por: Aft, R L, et al.
Publicado: (2012)

The evolving role of zoledronic acid in early breast cancer
por: Gnant, Michael
Publicado: (2009)

Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer – An AZURE (BIG 01/04) sub-study
por: Wilson, Caroline, et al.
Publicado: (2016)

Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences
por: D'Oronzo, Stella, et al.
Publicado: (2021)

Effectiveness of trastuzumab as adjuvant therapy in patients with early stage breast cancer: A systematic review and meta-analysis
por: Davari, Majid, et al.
Publicado: (2017)

Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer
por: El Saghir, Nagi S, et al.
Publicado: (2005)

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
por: Vidula, Neelima, et al.
Publicado: (2021)

Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
por: Sun, Shengliang, et al.
Publicado: (2016)

SUBTROCHANTERIC FRACTURE IN A PATIENT RECEIVING ZOLEDRONIC ACID THERAPY FOR METASTATIC BREAST CANCER
por: KISHIMOTO, YASUZUMI, et al.
Publicado: (2011)

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
por: Coleman, R.E., et al.
Publicado: (2018)

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
por: van Hellemond, Irene E. G., et al.
Publicado: (2018)

Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis
por: Lorange, Justin-Pierre, et al.
Publicado: (2023)

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor– positive early breast cancer
por: Verma, S., et al.
Publicado: (2009)

Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
por: Genuino, Anne Julienne, et al.
Publicado: (2019)

Anthracycline versus nonanthracycline adjuvant therapy for early breast cancer: A systematic review and meta-analysis
por: Ding, Wu, et al.
Publicado: (2018)

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
por: Spångeus, Anna, et al.
Publicado: (2020)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
por: Aft, Rebecca
Publicado: (2012)

Dosing of zoledronic acid with its anti-tumor effects in breast cancer
por: Zhao, Xinmin, et al.
Publicado: (2015)

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer
por: Awan, Arif, et al.
Publicado: (2020)

Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer
por: Towns, K., et al.
Publicado: (2008)

Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis
por: Dooley, William C, et al.
Publicado: (2011)

Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly
por: Sun, J, et al.
Publicado: (2017)

Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women
por: Canuas-Landero, Victor G., et al.
Publicado: (2021)

The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014)

Zoledronic Acid–Induced Interface Dermatitis
por: Succaria, Farah, et al.
Publicado: (2015)

Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis
por: Al-Agha, Abdulmoein E., et al.
Publicado: (2016)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
por: Agarwala, Sanjay, et al.
Publicado: (2019)

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials()
por: Pala, Laura, et al.
Publicado: (2023)

Adjuvant psychotherapy in early-stage bipolar disorder: A protocol for systematic review and meta-analysis
por: Chen, Qianfang, et al.
Publicado: (2021)

Detecting Early Biomechanical Effects of Zoledronic Acid on Femurs of Osteoporotic Female Rats
por: Palacio, Evandro Pereira, et al.
Publicado: (2012)

Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid
por: Kasai, Hidefumi, et al.
Publicado: (2020)

In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells
por: Ural, A Ugur, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ok0h84732qcga4vhdjkheobkg2